Articles tagged with Liver
Exosomes have emerged as potential treatments for liver fibrosis by targeting specific non-parenchymal cells involved in the disease process. They can deliver therapeutic cargo directly to these cells, inhibiting inflammation and scar formation.
Researchers will characterize initial environmental exposures and collect biospecimens and data from residents potentially impacted by the disaster. Investigators will evaluate biospecimens for early signs of liver dysfunction, detecting known liver carcinogen vinyl chloride.
Researchers found that low-dose aspirin reduced liver fat content by 10.2% compared to placebo in a phase 2 trial of 80 adults with MASLD. Aspirin also improved markers of liver health, suggesting potential benefits for patients with this condition.
Researchers from Florida Atlantic University suggest that selecting an OTC medication for mild COVID-19 symptoms should be based on the entire benefit-to-risk profile of the patient. They caution against using traditional NSAIDs like ibuprofen and naproxen due to their similar but greater side effect profiles compared to aspirin.
Researchers have developed a new, non-invasive technique called spleen stiffness measurement (SSM) to diagnose portal hypertension (PHT), a severe complication of chronic liver disease. SSM uses sound waves to assess the stiffness of the spleen and shows promise as an accurate and comfortable alternative to invasive procedures.
The study reveals that a gene called mTOR, which works like a GPS, directs the specialization of liver cells according to their position. After birth, the fluctuation in nutrient supply triggers the activation of this gene, completing the maturation of the liver.
Researchers have identified a gene responsible for the development of starvation-induced fatty liver in cavefish, which are able to protect their liver due to reduced fat accumulation. This genetic basis has implications for understanding and addressing liver conditions in humans, including Type 2 diabetes and obesity.
Research reveals a dynamic pattern of gene expression in liver fibrosis, with persistent effects even during regression. The study identifies key 'hub' genes that could be developed into biomarkers for future therapies.
A potentially fatal parasite has been discovered in the Colorado River in California, affecting dogs and causing liver and intestinal illness. Researchers confirm the presence of Heterobilharzia americana, a flatworm that can be transmitted through snails and water, highlighting the need for awareness and precautions among dog owners.
Scientists have successfully tested novel gene therapies in a whole human liver, opening up new avenues for treating life-threatening inherited diseases. The use of a normothermic liver perfusion system enables accurate testing of gene therapeutics directly in the clinical target organ.
Researchers found that Kupffer cells in liver respond to high cholesterol by removing excess, revealing the liver's role in regulating cholesterol levels. This discovery suggests atherosclerosis is a systemic disease affecting multiple organs.
A total of 736 ACLF patients were included in the study, with 54.6% experiencing extrahepatic organ failure (EHOF). MEHOF or SEHOF with brain failure indicated a worse prognosis. Risk stratification using EHOF characteristics effectively differentiated patients with different mortality risks.
The study found that Mancozeb exposure leads to increased reactive oxygen species, redox imbalance, and liver biomarker elevation. XBP1s and NOX4 gene expression is also upregulated in response to MZ toxicity, indicating potential for early bio-indicators of endoplasmic reticulum stress.
Researchers at Iowa State University have created a lab-grown liver organoid from turtles, enabling faster study of their unique adaptations with potential medical applications. The organoids mimic the liver's role in helping turtles survive extreme cold and oxygen deprivation.
The study analyzed cirrhosis mortality data from 2008 to 2020 in China, revealing a declining trend with exceptions for males aged 50-59 years, females aged 45-49 and 80-84 years. Greater mortality burdens were observed in males, older individuals, and rural areas
A team of scientists at The Hospital for Sick Children developed an innovative statistical approach to demonstrate the effectiveness of a medication in reducing disease progression and liver transplants in children with Alagille syndrome. Using data from an international real-world cohort, they found a 70% improvement in event-free sur...
Researchers found that obesity increases allosteric regulation during feeding and decreases it when fasting in mice livers. This disruption may lead to metabolic disorders like nonalcoholic fatty liver disease and Type 2 diabetes.
Researchers analyzed tissue and fecal samples from 90 stranded marine mammals to study the distribution of toxic elements. The study found that Risso's dolphins and short-finned pilot whales had high concentrations of mercury, cadmium, and lead, while dwarf sperm whales had low levels.
A study by UC Davis Health found that a single dose of BCG reduced liver tumor burden and extended the survival of mice with liver cancer. The vaccine boosted the body's immunity, leading to tumor shrinkage and improved liver function.
A University of Sydney study sheds light on the 2022 child hepatitis outbreak, finding that 'helper virus' infections were likely the cause. The study reveals that over 3,000 cases were reported globally, with six percent requiring liver transplants.
Researchers discovered that blocking efferocytosis pathway prevents immunosuppressive activity in macrophages, restoring T cell activation and reducing metastatic tumour burden. The study found PDAC metastases to show high levels of immunosuppressive macrophages, promoting tumour growth.
A CHLA research team found that socio-economic factors like family support, employment status, patient age, race, and language spoken can impact clinical outcomes. Children with limited social support systems and working caregivers have worse outcomes.
A small, wearable ultrasound sticker can monitor organ stiffness and detect subtle changes that signal disease progression. The device has been shown to identify early signs of acute liver failure in rats and may one day help doctors diagnose internal organ failure more effectively.
Researchers identified blood proteomic markers associated with hepatocellular carcinoma (HCC) in patients with cirrhosis. The study found a set of biomarkers, including TGF-β driven mechanistic biomarkers and Myostatin and Pyruvate Kinase M2, which may stratify risk for HCC.
A recent study published in Hepatology has investigated the connection between platelet function and complications in patients with cirrhosis. The researchers found that decreased platelet activation predicts hepatic decompensation and mortality, highlighting the importance of personalized therapeutic approaches.
Korea University researchers found that perioperative radiotherapy significantly improves survival rates among HCC patients at high risk of recurrence. The study suggests that radiotherapy can reduce recurrence and improve survival in these patients, providing a significant adjuvant treatment option.
Researchers at Karolinska Institutet developed a method to study liver function and disease using the cornea of mice eyes. They transplanted liver cells into the eyes, creating a non-invasive platform to monitor liver health over time.
A study from VCU School of Medicine and Richmond VA Medical Center found that up to 10.3% of veterans with dementia have high FIB-4 scores, indicating a likelihood of cirrhosis. Early detection and targeted interventions can reverse cognitive decline in these patients.
A recent study by University of Missouri researcher Mansoo Yu found that online weight loss interventions with counseling and social support are effective for middle-aged adults with obesity. The study identified two key features: professional health coaching and access to social support from other users, which led to significant long-...
A recent study published in the Journal of Clinical Gastroenterology found that liver biopsy was essential to making the correct diagnosis in over a third of cases. Biopsy was particularly valuable in diagnosing autoimmune hepatitis and was also used to diagnose liver fibrosis more than two-thirds of the time.
A nationwide study from Karolinska Institutet found that GLP1 agonists like Ozempic reduce the risk of cirrhosis and liver cancer in people with type 2 diabetes and chronic liver disease. Those who continued taking the medication for ten years were half as likely to develop severe liver disease.
Researchers have developed a novel sequential ultrasound molecular imaging (USMI) approach to identify non-alcoholic steatohepatitis (NASH), offering a potential noninvasive diagnostic tool. The method uses microbubbles targeting CD36 and ICAM-1 to visualize hepatic steatosis and inflammation.
Researchers at the University of Toronto found that the liver generates palmitic acid and sends it to the developing brain when dietary levels are low. The study highlights the importance of palmitic acid for brain health, particularly during development.
Researchers have discovered how pioneer transcription factors, such as FOXA and OCT4, coordinate with epigenetic repressors to safeguard cell fate, enabling precise manipulation of cell fate in cellular programming and reprogramming. This breakthrough has important implications for scaling up organoid and tissue engineering technology.
Researchers have successfully used mRNA technology to correct a rare genetic disease in mice, demonstrating its potential therapeutic use. The treatment corrected the lethal consequences of the disease and restored glutathione metabolism.
The study reveals that hepatoblasts along the portal vein receive Notch signaling and differentiate into bile duct epithelial cells. Hematopoietic cells fail to transmit signals, resulting in the failure of differentiation. This discovery provides molecular biological support for mathematical analysis results.
Researchers at UMCG have successfully performed liver transplants after prolonged preservation using a perfusion machine, showing similar outcomes to immediate transplants. The new method allows for safer and more efficient liver transplantation during the day, reducing complications and mortality rates.
The £30M ADVANCE study aims to accelerate the development of new therapies for people with liver cirrhosis by identifying translational biomarkers. Researchers will enroll 200 patients with cirrhosis and use advanced techniques to analyze gene expression, blood tests, and MRI scans.
A new technique, CLivD score, has been developed to improve liver fibrosis treatment. The study found that the CLivD score can identify at-risk individuals, reducing the need for further evaluation and streamlining screening. This approach holds promise for early detection of liver disease and preventing complications.
A Learning Health System model is being developed to increase organ donation and reduce disparities in access to transplantation. The project, led by Hennepin Healthcare Research Institute, will use data tools to track progress and improve equity in organ donation across the US.
Research reveals SARS-CoV-2 RNA presence in extracellular vesicles of patients with negative PCR tests, suggesting a potential source for recurrent infections. The discovery may aid in identifying individuals with persistent or recurrent COVID-19 infections and offer new avenues for therapeutic interventions.
Researchers from Osaka Metropolitan University investigated the credibility and efficiency of generative AI tools in collecting medical literature. The study found that Elicit outperformed ChatGPT, suggesting multiple references with high accuracy within minutes.
A new stem cell treatment using mRNA technology from COVID-19 vaccines has shown promise in regenerating liver tissue, potentially reversing chronic and acute liver diseases. The treatment stimulates the natural repair mechanism of the liver by activating specific receptors on stem cells.
Gene therapy treatments can prompt an adverse immune reaction when the body mistakenly perceives the treatment as a viral threat. Researchers have identified a critical pathway in the liver that triggers this response, but also found a way to block it, paving the way for safer and more precise gene therapy options.
A new study provides an updated assessment of hepatorenal syndrome-acute kidney injury (HRS-AKI), a potentially reversible but often fatal condition. The study's findings highlight the importance of early recognition and standard pharmacological treatment, with only 40%–50% of patients experiencing restored kidney function.
Scientists have developed a drug-eluting hydrogel that provides sustained, pH-dependent drug co-delivery and promotes anti-tumor immune responses, reducing tumor cell proliferation and growth. The treatment shows promise in treating hepatocellular carcinoma, with enhanced efficacy compared to traditional methods.
Researchers at Osaka Metropolitan University have successfully developed a novel pneumococcal vaccine that demonstrates efficacy in suppressing pneumococcal pneumonia in macaques. The vaccine's design combines proprietary mucosal vaccine technology with pneumococcal surface proteins to cover a wide range of serotypes.
Researchers found that 1,8-cineole inhibits inflammatory pathways in the gut, while ginsenoside Rk2 alleviates liver inflammation and restores intestinal barrier function. Another compound, specnuezhenide, modifies gut microbiota and has potential to inhibit colorectal tumor growth.
A study of over 2.9 million patients found that gender concordance was associated with lower mortality for female patients, but higher mortality for male patients. The quality of surgical care provided by female surgeons is equivalent to or slightly better than that provided by male surgeons.
Researchers found intestinal hormones can inactivate liver's star-like cells responsible for scar tissue formation. This discovery could lead to new treatments targeting cell changes, avoiding severe side effects.
Researchers developed a new risk assessment system to identify patients with low-risk profiles who can benefit from liver stents. These patients have a significantly higher mortality rate than previously thought, highlighting the need for targeted treatment and further personalization.
Researchers found that pollutants in green sea turtle eggs can feminize broods, increasing the risk of extinction due to a lack of males. The study suggests that climate change and pollution may be driving this trend, which could have severe consequences for the species' survival.
A new therapeutic, lepodisiran, has shown promising results in reducing lipoprotein(a) levels to undetectable levels for nearly one year. The study found that the medication is safe and effective in lowering Lp(a) levels by more than 94%.
A new smartphone app using the APRI+ALBI score increases the safety of liver surgery by providing an individualized risk assessment for patients prior to resection. The score offers a cheaper and less invasive option with comparable predictive power compared to standard preoperative tests.
Researchers from the Max Planck Research Group aim to investigate the local immune system of the liver to develop new immunotherapy strategies for metastatic diseases. They will examine tissue and tumor samples using state-of-the-art techniques to identify key molecules and checkpoints in complex cellular interaction networks.
Researchers at Children's Hospital Los Angeles have developed a novel app called the CHALF score to predict if a child with acute liver failure needs a transplant. The tool assesses liver failure risk on a scale of 5-60 and has been shown to accurately predict patient outcomes.
Researchers from Columbia University have validated GLS2's ability to promote ferroptosis in murine models. This study suggests that targeting GLS2 may be a potential therapeutic strategy against liver diseases, particularly hepatocellular carcinoma.
Researchers at UC San Diego discovered that liver cells use vesicle exchange to share molecules and multiply, a process also found in various types of cancer cells. This mechanism could be a universal driver of resistance to cancer therapies targeting cell proliferation.
A new study published in JAMA Network Open found live vaccinations safe and effective for children who have received liver or kidney transplants, offering protection against life-threatening conditions. The study showed high antibody levels and minimal adverse events following vaccination.
A new clinical trial has shown that infusing immune cells from living donors into recipients before transplantation may reduce the need for lifelong immunosuppressant medication. The treatment involves infusing donor-derived regulatory dendritic cells, which help the recipient's immune system distinguish between foreign and self-cells.